-
AVIESAN
- Functional Manager of the Aviesan Tech Transfer Consortium
2016 - maintenant
Aviesan is the French National Alliance for Life Sciences and Health.
The objective of the tech transfer consortium (CVT Aviesan) is to bring out a national strategic view in the areas in which there seems to be an opportunity for investment. This vision is organized into strategic valorization fields (DVSs).
-
AVIESAN
- Business Development Manager in Strategic Field
2015 - maintenant
Strategic Field of Development - Biomarkers in Neurology and Psychiatry.
We organise a close dialogue between researchers, clinicians, manufacturers and those involved in innovation, funding and regulation, in order to facilitate the emergence of innovative projects to help provide relevant biomarkers for neurology and psychiatry.
-
Pherecydes Pharma
- Head of R&D, CSO
2007 - 2015
PHERECYDES PHARMA is a biopharmaceutical company developing new products against emerging bacteria, combining surveillance, detection and therapeutic tools based on phage technology.
Diversified libraries of bacteriophages are created by stochastic recombination of their targeting system, and biotechnological applications are derived, such as miniaturized biosensors and pharmaceutical applications.
Our mission is to develop new tools to rapidly detect and treat people and their environment against a large range of biothreat agents, including multi-resistant, emergent or previously uncharacterized bacteria.
The diversity of our phage libraries allied to the exceptional properties of bacteriophages allow us to address infectious problems in biodefense, environmental hygiene, food safety, veterinary and human therapeutics.
-
Pasteur Institute
- PhD
2003 - 2006
Study on one major bioterrorism bacteria : Yersinia pestis, agent of plague (level safety 3.)
PhD study on very competitive subject.
Thorough knowledge on pathogenicity mechanism by mutagenesis.
4 publications in international peer-review journals.
